(NYSE: PFE) announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist
As a reminder from our piece about GLP-1s, the hormone helps regulate blood sugar levels by: Stimulating insulin secretion in response to high blood glucose Slowing gastric emptying, which helps with appetite control and weight management Reducing the liver's glucose production Side Effects are Easier to Manage with Support As with any medication, its essential to understand its benefits and potential side effects you may experience
This innovative delivery system encapsulates glutathione within tiny, lipid-based vesicles called liposomes, significantly enhancing its absorption and bioavailability
MTC's weight loss maintenance program emphasizes follow-up, accountability, and adjustment as health and lifestyle needs change
Asha was a pharmacist, entrepreneur, wife, mother, colleague, friend, and so much more
Lower protein intake